MORC2 mutation causes severe spinal muscular atrophy-phenotype, cerebellar atrophy, and diaphragmatic paralysis

Authors:

Abstract
Sir, With great interest, we read the article by Sevilla et al. (2016) delineating mutations in MORC 2 as a novel genetic cause for axonal Charcot-Marie-Tooth (CMT) disease type 2Z (OMIM #616688) with dominant inheritance. The authors detected MORC2 mutations in nine patients from three unrelated families and showed MORC2 to be expressed in both axons and Schwann cells of the peripheral nerve (Sevilla et al. , 2016). MORC2 belongs to the group of highly conserved MORC proteins, which all share CW-zinc finger and GHL (Gyrase B-Hsp90-MutL)-ATPase domains (Li et al. , 2013). MORC2 is predominantly expressed in the nucleus and is supposed to be relevant for chromatin remodelling, DNA-repair, transcriptional regulation, and lipid metabolism (Shao et al. , 2010; Li et al. , 2012). Following publications describing seven mutations underline the importance of this gene as a novel cause for CMT (Albulym et al. , 2016; Hyun et al. , 2016; Laššuthová et al. , 2016; Zhao et al. , 2016). Following this publication, we re-examined whole exome and whole genome sequencing data of a cohort of 32 patients from 23 families with genetically unsolved neuropathies for mutations in MORC2 and identified a novel de novo c.1085C>G (p.T362R) MORC2 mutation. The 5-year-old girl did not show a CMT phenotype but suffered from severe spinal muscular atrophy (SMA)-like disease with neuropathy, cerebellar atrophy, and diaphragmatic paralysis. This observation broadens the phenotypical spectrum of MORC2 -related disorders towards SMA, spinal muscular atrophy with respiratory distress type 1 (SMARD1), and pontocerebellar hypoplasia. The study was approved by the institutional review board of the Charité (EA1/222/08). Parents provided written informed consent for all aspects of the study according to the Declaration of Helsinki. The now …